Schedule

Genetron Health Enters into Definitive Merger Agreement for Going Private Transaction

Retrieved on: 
Wednesday, October 11, 2023
Slate, Canadian House of Commons Special Committee on Electoral Reform, LLP, King & Wood Mallesons, Skadden, Arps, Slate, Meagher & Flom, Consortium, Schedule, Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, US, Wardwell, Form 6-K, Tripura Merger Agreement, CICC, Person, Neal, Sub, Latham & Watkins, Proxy, Committee, Limited partnership, GTH, III, ODI, ADS, CCB, AND, Holding company, Security (finance), Auction, PRC, Parent, Share (finance), Mergers and acquisitions

BEIJING, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced today that it has entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with New Genetron Holding Limited (“Parent”) and Genetron New Co Limited (“Merger Sub”), a wholly-owned subsidiary of Parent.

Key Points: 
  • BEIJING, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced today that it has entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with New Genetron Holding Limited (“Parent”) and Genetron New Co Limited (“Merger Sub”), a wholly-owned subsidiary of Parent.
  • The Board, acting upon the unanimous recommendation of a committee of independent and disinterested directors established by the Board (the “Special Committee”), approved the Merger Agreement and the Merger and resolved to recommend the Company’s shareholders vote to authorize and approve the Merger Agreement and the Merger.
  • The Special Committee negotiated the terms of the Merger Agreement with the assistance of its financial and legal advisors.
  • In connection with the Merger, the Company will prepare and mail to its shareholders a proxy statement that will include a copy of the Merger Agreement.

Safeguard Scientifics’ Board of Directors Approves Plan to Voluntarily Terminate Registration of Its Common Stock with the SEC and Voluntarily Delist from Nasdaq

Retrieved on: 
Thursday, October 5, 2023
Schedule, Pete Musser, Special, Minimum number of individuals, Reverse stock split, Maxima and minima, Safeguard, Cash out refinancing, SFE, Cryptocurrency, Security (finance)

In order to deregister its shares of common stock, the Company must reduce its number of shareholders of record to below 300.

Key Points: 
  • In order to deregister its shares of common stock, the Company must reduce its number of shareholders of record to below 300.
  • Upon the forward stock split, the shares of common stock (including any fraction of a share of common stock) held by such Continuing Shareholders after the reverse stock split will be reclassified into the same number of shares of common stock as such Continuing Shareholders held immediately prior to the effective time.
  • As a result of the forward stock split, the total number of shares of common stock held by a Continuing Shareholder would not change due to the stock splits.
  • If the Stock Split Proposals are approved by shareholders at the Special Meeting and the Board decides to proceed with the going private transaction, the Company will take steps to terminate the registration of its common stock with the SEC and delist its common stock from trading on Nasdaq.

SEC Adopts Amendments to Rules Governing Beneficial Ownership Reporting

Retrieved on: 
Tuesday, October 10, 2023
Schedule, Schedule 13D, Register, Passive investor, Person, Federal Register, Security (finance)

Washington, D.C.--(Newsfile Corp. - October 10, 2023) - The Securities and Exchange Commission today adopted rule amendments governing beneficial ownership reporting under Sections 13(d) and 13(g) of the Securities Exchange Act of 1934.

Key Points: 
  • Washington, D.C.--(Newsfile Corp. - October 10, 2023) - The Securities and Exchange Commission today adopted rule amendments governing beneficial ownership reporting under Sections 13(d) and 13(g) of the Securities Exchange Act of 1934.
  • The amendments update Regulation 13D-G to require market participants to provide more timely information on their positions to meet the needs of investors in today’s financial markets.
  • “Today’s adoption updates rules that first went into effect more than 50 years ago.
  • Frankly, these deadlines from half a century ago feel antiquated,” said SEC Chair Gary Gensler.

Alfasigma S.p.A. Tender Offer for Intercept Pharmaceuticals, Inc. Commences

Retrieved on: 
Wednesday, October 11, 2023
Health, Pharmaceutical, Intercept Pharmaceuticals, Schedule, Eastern Time Zone, 600 (number), Risk, USD, Agreement, Transaction, Intercept, Failure, Expiration, Tax, Computershare, Money transmitter, Plan, Hart–Scott–Rodino Antitrust Improvements Act, Annual report, Letter, Uncertainty, Ix, Nature, Security (finance), Cryptocurrency, Pamlab

Alfasigma will file today a Tender Offer Statement on Schedule TO with the United States Securities and Exchange Commission (the “SEC”).

Key Points: 
  • Alfasigma will file today a Tender Offer Statement on Schedule TO with the United States Securities and Exchange Commission (the “SEC”).
  • The Offer to Purchase contained within the Schedule TO sets out the full terms and conditions of the Offer.
  • This press release is neither an offer to purchase nor a solicitation of an offer to sell securities, nor is it a substitute for any tender offer materials that Intercept or Alfasigma will file with the SEC.
  • On October 11, 2023, Purchaser and Alfasigma will file a Tender Offer Statement on Schedule TO with the SEC and Intercept will file a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC, in each case with respect to the Offer.

Edison International Commences Tender Offers to Purchase Its 5.00% Fixed-Rate Reset Cumulative Perpetual Preferred Stock, Series B and 5.375% Fixed-Rate Reset Cumulative Perpetual Preferred Stock, Series A For a Maximum Aggregate Purchase Price…

Retrieved on: 
Wednesday, October 11, 2023
Utilities, Energy, ACT, MAKE, NOR, Schedule, Security, Settlement date, ITS, Mizuho Securities, Edison International, Barclays Capital Inc. v. Theflyonthewall.com, Inc., Communication, Bangladesh Securities and Exchange Commission, Priority, Expiration, Trust, Venture round, Expiration date, ARE, Person, LAWS, Letter, Hand, Name, Security (finance), AT, Auction, Offers, Letter of transmittal

The Series B Offer has been assigned an Acceptance Priority Level of 1 and the Series A Offer an Acceptance Priority Level of 2.

Key Points: 
  • The Series B Offer has been assigned an Acceptance Priority Level of 1 and the Series A Offer an Acceptance Priority Level of 2.
  • Accordingly, all Securities validly tendered in the Series B Offer will be accepted for purchase before any validly tendered Securities of the Series A Offer are accepted.
  • In that event, the Series A Preferred Stock that will be accepted for purchase will be subject to proration, as described in the Offer to Purchase.
  • THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT AN OFFER OR SOLICITATION TO PURCHASE SECURITIES.

American Strategic Investment Co. Announces Response to Bellevue Capital Partners, LLC Tender Offer

Retrieved on: 
Tuesday, October 10, 2023
Commercial Building & Real Estate, Construction & Property, Tender offer, NYSE, Schedule, Bangladesh Securities and Exchange Commission, Security (finance), Letter, Cryptocurrency

American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today that it has filed with the Securities and Exchange Commission (“SEC”) a Solicitation/Recommendation Statement on Schedule 14D-9 and Letter to Stockholders dated October 10, 2023, regarding the tender offer commenced by Bellevue Capital Partners, LLC (“Bellevue”) on September 27, 2023, to purchase up to 350,000 shares of the Company’s Class A common stock at a price of $10.25 per share (the “Tender Offer”).

Key Points: 
  • American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today that it has filed with the Securities and Exchange Commission (“SEC”) a Solicitation/Recommendation Statement on Schedule 14D-9 and Letter to Stockholders dated October 10, 2023, regarding the tender offer commenced by Bellevue Capital Partners, LLC (“Bellevue”) on September 27, 2023, to purchase up to 350,000 shares of the Company’s Class A common stock at a price of $10.25 per share (the “Tender Offer”).
  • The Company’s board of directors has made no determination of the fairness of the Tender Offer or whether it is in the best interests of stockholders, makes no recommendation and is neutral as to whether stockholders should accept or reject the offer to tender their shares.
  • The Company urges each stockholder to review the Schedule 14D-9 and the accompanying Letter to Stockholders as well as the tender offer materials sent by Bellevue and to make its own decision regarding the Tender Offer based on the available information.
  • The Tender Offer will expire at 11:59 PM, New York City time, on October 26, 2023, unless extended or earlier terminated by Bellevue.

SOUTHWEST AIRLINES ANNOUNCES LEADERSHIP PROMOTIONS

Retrieved on: 
Monday, October 16, 2023
Aircraft, Partnership, Senior, Oklahoma State University–Stillwater, Jordan, NYSE, University, Income Tax Department, Schedule, Fleet management, Moses Austin, Customer support, Union Pacific Railroad, Vesta C. Muehleisen, Engagement, Southwest Airlines, Finance, Amadeus, Wilson v Southwest Airlines Co, Corporation for Education Network Initiatives in California, Education, Culture, Boeing, Travel, FAA, Analysis, Flight dispatcher, Aviation, NOC, Compensation, Baylor University, Retirement, Airline, Management, Safety

DALLAS, Oct. 16, 2023 /PRNewswire/ -- Southwest Airlines Co. (NYSE: LUV) today announced recent Leadership updates across the Company.

Key Points: 
  • DALLAS, Oct. 16, 2023 /PRNewswire/ -- Southwest Airlines Co. (NYSE: LUV) today announced recent Leadership updates across the Company.
  • Prior to Southwest, Stephens held various positions in leadership and operations with Union Pacific Railroad.
  • "Strong Leadership is built upon serving, and Southwest Airlines boasts a longstanding tradition of remarkable Leaders who consistently prioritize the needs of our Employees and Customers over their own," said Bob Jordan , President & CEO at Southwest Airlines.
  • "I extend my sincere appreciation to Matt Hafner for his 35 years of service at Southwest Airlines.

Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions

Retrieved on: 
Wednesday, October 4, 2023
Letter, Enhanced, Marketing, TD Ameritrade, European Medicines Agency, COVID-19, Infection, Form 10-K, Transmittal document, HERE, Bangladesh Securities and Exchange Commission, Schedule, Harmony, Less Commonly Taught Languages, Growth, Security (finance), Annual report, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Action Replay, Holding company, Cryptocurrency

The Zynerba Board of Directors unanimously recommends that Zynerba stockholders tender their shares pursuant to the Offer.

Key Points: 
  • The Zynerba Board of Directors unanimously recommends that Zynerba stockholders tender their shares pursuant to the Offer.
  • Zynerba stockholders must tender their shares by 5:00 p.m., New York City time, on Tuesday, October 10, 2023.
  • How to Tender Your Shares:
    If you hold shares of Zynerba common stock through a broker, dealer, commercial bank, trust company or other nominee, you must instruct such broker or other nominee to tender your shares.
  • Do not wait until the tender deadline to tender your shares as they may not be counted.

Zoomtopia 2023: One platform delivering limitless human connection

Retrieved on: 
Tuesday, October 3, 2023
Data management, Communication, WhatsApp, Meta, Table, CX, Wayfinding, Schedule, Documentation, SAN, Map, Ecosystem, AI, ZM, Whiteboard, Messenger, Telescopic sight, Customer service, Sales, Satellite navigation device, Online shopping, Calendar, Meeting, Huddle, Zoom, Salesforce

Zoom’s breakthrough product, Zoom Docs , is a next-gen way of collaborating, built from the ground up with AI at its core.

Key Points: 
  • Zoom’s breakthrough product, Zoom Docs , is a next-gen way of collaborating, built from the ground up with AI at its core.
  • Zoom Docs includes traditional document capabilities, as well as wikis and drag-and-drop content blocks for tables, charts, and images.
  • Delivering an exceptional employee experience in the hybrid work era that supports employees across different work styles is critical for companies to succeed.
  • For more information on additional enhancements to Zoom Meetings, Zoom Rooms, and other Zoom One products, visit the Zoom newsroom .

Top Strike Announces 2024 First Quarter Financial Results ending July 31, 2023 and Corporate Update

Retrieved on: 
Friday, September 29, 2023
Treasury, IRC, CSE, SAFE Banking Act, CGT, Senate, Senior, CRC, HHS, Conversion, Classification, SAFE, SAFER, Majority, Secure, TGC, Schedule, II, New Jersey Cannabis Regulatory Commission, Congress, Conditional, DEA, Investment, Gold, BID, Financial result, Transaction, Cannabis, United States Senate Committee on Banking, Housing, and Urban Affairs, Warrant (finance), Drug, Cryptocurrency, Security (finance)

As at July 31, 2023, 57% of the Company's assets was directly related to US cannabis activities.

Key Points: 
  • As at July 31, 2023, 57% of the Company's assets was directly related to US cannabis activities.
  • The Company generated $149,995 (2022 - $97,942) in interest income from its short-term treasury deposits and two receivable notes.
  • Expenses for the three months ended July 31, 2023, were $236,900 (2022 - $277,992).
  • On August 16, 2023, the Company amended and restated its definitive agreement with Cannavative (the "A&R Definitive Agreement" or the "Transaction").